0
0
1/20/23 at 6:33am
Organization
Neurologyadvisor.com
39 words
0
Comments
These are the clinical trials that led to the FDA's approval of aducanumab and lecanemab for early AD, plus, the concerns that loom.
You are the first to view
https://www.neurologyadvisor.com/topics/alzheimers-disease-and-dementia/aducanumab-lecanemab-early-ad-clinical-trials-fda-approval/
Create an account
or login to join the discussion